These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2003306

  • 1. Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils.
    Hall ED, Pazara KE, Braughler JM.
    Stroke; 1991 Mar; 22(3):361-6. PubMed ID: 2003306
    [Abstract] [Full Text] [Related]

  • 2. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion.
    Andrus PK, Taylor BM, Sun FF, Hall ED.
    Brain Res; 1994 Oct 03; 659(1-2):126-32. PubMed ID: 7820653
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury.
    Sato PH, Hall ED.
    J Neurochem; 1992 Jun 03; 58(6):2263-8. PubMed ID: 1573405
    [Abstract] [Full Text] [Related]

  • 5. Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia.
    Park CK, Hall ED.
    Brain Res; 1994 May 09; 645(1-2):157-63. PubMed ID: 8062078
    [Abstract] [Full Text] [Related]

  • 6. 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils.
    Hall ED, Pazara KE, Braughler JM.
    Stroke; 1988 Aug 09; 19(8):997-1002. PubMed ID: 3400111
    [Abstract] [Full Text] [Related]

  • 7. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F).
    Althaus JS, Andrus PK, Williams CM, VonVoigtlander PF, Cazers AR, Hall ED.
    Mol Chem Neuropathol; 1993 Oct 09; 20(2):147-62. PubMed ID: 8297419
    [Abstract] [Full Text] [Related]

  • 8. The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation.
    Wang Y, Mathews WR, Guido DM, Jaeschke H.
    J Pharmacol Exp Ther; 1996 May 09; 277(2):714-20. PubMed ID: 8627550
    [Abstract] [Full Text] [Related]

  • 9. Amelioration of impaired cerebral metabolism after severe acidotic ischemia by tirilazad posttreatment in dogs.
    Kim H, Koehler RC, Hurn PD, Hall ED, Traystman RJ.
    Stroke; 1996 Jan 09; 27(1):114-21. PubMed ID: 8553386
    [Abstract] [Full Text] [Related]

  • 10. Nonsteroidal lazaroid U78517F in models of focal and global ischemia.
    Hall ED, Pazara KE, Braughler JM, Linseman KL, Jacobsen EJ.
    Stroke; 1990 Nov 09; 21(11 Suppl):III83-7. PubMed ID: 2237990
    [Abstract] [Full Text] [Related]

  • 11. Tirilazad treatment does not decrease early brain injury after transient focal ischemia in cats.
    Takeshima R, Kirsch JR, Koehler RC, Traystman RJ.
    Stroke; 1994 Mar 09; 25(3):670-6. PubMed ID: 8128524
    [Abstract] [Full Text] [Related]

  • 12. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats.
    Xue D, Slivka A, Buchan AM.
    Stroke; 1992 Jun 09; 23(6):894-9. PubMed ID: 1595111
    [Abstract] [Full Text] [Related]

  • 13. Tirilazad prevention of reperfusion edema after focal ischemia in cynomolgus monkeys.
    Boisvert DP, Hall ED.
    Can J Neurol Sci; 1996 Feb 09; 23(1):46-52. PubMed ID: 8673962
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide is neuroprotective in a gerbil model of transient severe focal cerebral ischemia: correlation with effects of tirilazad mesylate (U-74006F).
    Williams LR, Oostveen JA, Hall ED, Jolly RA, Satoh PS, Petry TW.
    J Neurotrauma; 1996 Feb 09; 13(2):103-13. PubMed ID: 9094381
    [Abstract] [Full Text] [Related]

  • 15. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot.
    Kanamaru K, Weir BK, Simpson I, Witbeck T, Grace M.
    J Neurosurg; 1991 Mar 09; 74(3):454-9. PubMed ID: 1993911
    [Abstract] [Full Text] [Related]

  • 16. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury.
    Smith SL, Scherch HM, Hall ED.
    J Neurosurg; 1996 Feb 09; 84(2):229-33. PubMed ID: 8592225
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect of tirilazad mesylate (U-74006F), mannitol, and their combination on experimental ischemia.
    Oktem IS, Menkü A, Akdemir H, Kontaş O, Kurtsoy A, Koç RK.
    Res Exp Med (Berl); 2000 Feb 09; 199(4):231-42. PubMed ID: 10743681
    [Abstract] [Full Text] [Related]

  • 18. Studies of ischemia-reperfusion injury in skeletal muscle: efficacy of 21-aminosteroids on microcirculation and muscle contraction after an extended period of warm ischemia.
    Korompilias AV, Chen LE, Seaber AV, Urbaniak JR.
    J Orthop Res; 1997 Jul 09; 15(4):512-8. PubMed ID: 9379260
    [Abstract] [Full Text] [Related]

  • 19. Protection against postischemic spinal cord injury using a new 21-aminosteroid.
    Fowl RJ, Patterson RB, Gewirtz RJ, Anderson DK.
    J Surg Res; 1990 Jun 09; 48(6):597-600. PubMed ID: 2362420
    [Abstract] [Full Text] [Related]

  • 20. Effect of the 21-aminosteroid tirilazad on cerebral pH and somatosensory evoked potentials after incomplete ischemia.
    Maruki Y, Koehler RC, Kirsch JR, Blizzard KK, Traystman RJ.
    Stroke; 1993 May 09; 24(5):724-30. PubMed ID: 8488529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.